期刊
BLOOD
卷 120, 期 22, 页码 4311-4316出版社
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2012-01-403022
关键词
-
类别
资金
- Danish Cancer Foundation [DP05112/ R2-A41-09-S2]
- Danish Medican Research Council [271-07-0452, 09-072265]
- Novo Nordic Foundation
- Sophus Carl Emil Friis and wife Olga Doris Friis' Foundation
- Lundbeck Foundation
- University Hospital of Copenhagen
Some women suffering from leukemia require bone marrow transplantation to be cured. Bone marrow transplantation is associated with a high risk of sterility, and some patients are offered fertility preservation by cryopreservation of the ovarian cortex. Transplantation of the ovarian cortex to women cured of leukemia who became menopausal is currently not performed because of the risk of introducing the disease. In this study, individual pieces of ovarian cortex intended for reimplantation from 25 patients with leukemia were transplanted to each of 25 nude mice for 20 weeks. The ovarian cortex was examined before and after transplantation by histology and immunohistochemistry, and RT-quantitative PCR (in the 7 patients with a known marker). Seventeen patients had the ovarian cortex retrieved when they were in complete remission. Before transplantation, 4 of 7 pieces (2 from patients in complete remission) of ovarian cortex had a positive RT-quantitative PCR. After transplantation, none of the mice revealed any sign of disease, neither in the pieces of ovarian cortex transplanted nor in any of the murine organs evaluated. Thus, the ovaries from patients in complete remission do not appear to contain viable malignant cells contrasting ovarian tissue retrieved before treatment. (Blood. 2012;120(22):4311-4316)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据